Machine learning for determining lateral flow device results for testing of SARS-CoV-2 infection in asymptomatic populations

Rapid antigen tests in the form of lateral flow devices (LFDs) allow testing of a large population for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To reduce the variability in device interpretation, we show the design and testing of an artifical intelligence (AI) algorithm based on...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513327/
https://www.ncbi.nlm.nih.gov/pubmed/36240756
http://dx.doi.org/10.1016/j.xcrm.2022.100784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513327/
https://www.ncbi.nlm.nih.gov/pubmed/36240756
http://dx.doi.org/10.1016/j.xcrm.2022.100784

Ejemplares similares